Industry News
Nox Health Closes Acquisition of Somryst, the Only FDA-cleared Digital Insomnia Treatment
Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, recently announced that it has closed the acquisition of Somryst, the first and only FDA-approved prescription digital therapeutic that delivers effective, first-line treatment for adults with chronic insomnia.